...
首页> 外文期刊>Drug testing and analysis >Monitoring of direct alcohol markers in alcohol use disorder patients during withdrawal treatment and successive rehabilitation
【24h】

Monitoring of direct alcohol markers in alcohol use disorder patients during withdrawal treatment and successive rehabilitation

机译:在戒断治疗和连续康复期间,监测酒精使用障碍患者的直接酒精标志物

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Direct and indirect biomarkers are widely applied for the determination of alcohol consumption. They help to assess past or present alcohol consumption. Depending on the window of detection and sensitivity of the investigated marker, punctual alcohol consumption may remain undetected. In this study, different sampling strategies for the intermediary long-term marker phosphatidylethanol (PEth) are evaluated and compared to the determination of the short-term markers ethyl glucuronide (EtG) and ethyl sulfate (EtS) in urine. Samples from 19 patients undergoing alcohol use disorder treatment were collected during the withdrawal treatment and successive rehabilitation (33 +/- 26 days (range: 3-74 days)). With liquid chromatography-tandem mass spectrometry (LC-MS/MS) EtG and EtS in urine, PEth in blood, PEth in dried blood spot (DBS) from venous blood, and PEth in DBS from capillary blood were quantified and compared. The use of volumetric capillary DBS, prepared from 20 mu L of blood, provided the same results as the use of venous DBS (95% +/- 10%, R-2 0.9899 for PEth 16:0/18:1). Capillary DBS sampling has the advantage that it can be performed without venipuncture. The use of PEth in DBS proved to prevent post-sampling degradation, providing a longer detection in comparison to PEth in liquid blood, which only showed 67% +/- 24% of the PEth DBS 16:0/18:1 concentration. When compared with EtG and EtS in urine, PEth monitoring proved to be advantageous for the detection of relapse situations, as the accumulation of PEth in blood prolongs the detectability. In conclusion, volumetric capillary DBS sampling for PEth is a simple and useful tool for compliance monitoring, and avoids hematocrit issues.
机译:直接和间接生物标志物被广泛应用于醇消耗的测定。他们有助于评估过去或呈现酒精消费。根据所研究标记的检测和灵敏度窗口,可持续未检测到的准时的醇消费。在该研究中,评估中间体长期标记磷脂酰乙醇(Peth)的不同取样策略,并与尿液中的短期标记物乙基葡糖(ETG)和硫酸乙酯(ETS)的测定进行比较。在戒断治疗和连续康复期间收集来自19名饮酒障碍治疗的患者的样品(33 +/- 26天(范围:3-74天))。通过液相色谱 - 串联质谱(LC-MS / MS)ETG和尿液中的ET,血液中的Peth,在静脉血干血斑(DBS)中的Peth,量化毛细血血液中的DBS中的Peth。使用20μL血液中制备的体积毛细管DBS,提供了与静脉DBS的使用相同的结果(95%+/- 10%,r-2 0.9899用于第16:0/18:1)。毛细管DBS采样具有以下优点,即可以在没有静脉穿刺的情况下进行。在DBS中使用Peth的使用证明是防止后测的降解,与液体血液中的Peth相比,较长的检测,该液体仅显示了Peth DBS 16:0/18:1浓度的67%+/- 24%。与尿液中的ETG和ETS相比,Peth监测证明是有利的,对复发情况进行检测,因为血液中PETH的积累延长了可检测性。总之,Peth的体积毛细管DBS采样是合规监测的简单且有用的工具,避免了血细胞比容问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号